Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.02 (+1.89%)
As of: Oct 2, 2026 · 9:42 AM EDT

Rani Therapeutics Holdings (RANI) Total Current Liabilities (2020 - 2026)

Updated

Rani Therapeutics Holdings' Total Current Liabilities was $10.64 million in Q2 2026, down 48.4% from $20.62 million a year earlier and down 23.2% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Rani Therapeutics Holdings came in at $12.67 million, down 36.3% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 19.0% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $19.89 million in FY2024 (+149.0%), $7.99 million in FY2023 (+65.9%), $4.82 million in FY2022 (+82.4%) and $2.64 million in FY2021 (-50.3%).
  • The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q4 2023.
  • Compared with a year earlier, Total Current Liabilities has declined for four straight quarters, with growth averaging 34.7% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q2 2024 (growth of 189.1%); the worst was Q4 2021 (a decline of 50.3%).
  • Per Business Quant data, RANI's Total Current Liabilities in the three quarters before Q2 2026 was $13.86 million (Q1 2026), $12.67 million (Q4 2025) and $19.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 10.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.64 Mn
Mar 31, 2026 13.86 Mn
Dec 31, 2025 12.67 Mn
Sep 30, 2025 19.14 Mn
Jun 30, 2025 20.62 Mn
Mar 31, 2025 20.13 Mn
Dec 31, 2024 19.89 Mn
Sep 30, 2024 20.21 Mn
Jun 30, 2024 16.58 Mn
Mar 31, 2024 13.38 Mn
Dec 31, 2023 7.99 Mn
Sep 30, 2023 7.35 Mn
Jun 30, 2023 5.74 Mn
Mar 31, 2023 5.15 Mn
Dec 31, 2022 4.82 Mn
Sep 30, 2022 7.19 Mn
Jun 30, 2022 5.35 Mn
Mar 31, 2022 4.16 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 5.25 Mn
API Access

Rani Therapeutics Holdings Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RANI&period=max&api_key=YOUR_API_KEY